An Oxford-based company has begun testing Novel virus-like particulate (VLP) vaccines for Covid-19 with its Indian partner company Serum Institute of India (SIIPL). This vaccine has the potential to combat the pandemic.
Several Coronavirus vaccine is being developed across the world to combat the global pandemic. Meanwhile, an Oxford-based company of Indian origin professor is testing it's novel virus-like particulate (VLP) vaccine for dealing with the COVID-19 pandemic. Early results show that the vaccine has the required ability to fight Coronavirus infection without any side-effects.
The Chief Executive Officer and co-founder of Spy Biotech, Professor Sumi Biswas said that the first and second phase of VLP testing has been completed.
Spy Biotech said it had signed a special global licensing agreement with SIIPL to develop the vaccine based on research conducted in Australia.
Meanwhile, India has become a global hotspot of the pandemic. According to the Union Ministry of Health and Family Welfare, as many as 89,706 new COVID-19 cases and 1,115 deaths were reported in the country in the last 24 hours, marking a significant spike.
With over 89,000 new cases reported in the last 24 hours, India's COVID-19 count on September 9 crossed the 43 lakh-mark, while the death toll is nearing the 74,000-mark as well.
The COVID-19 tally in the country has reached 43,70,129 cases, which include 8,97,394 active cases; 33,98,845 cured, discharged, or migrated patients, and 73,890 deaths.
Total coronavirus cases in the worst-hit state of Maharashtra have crossed the 9.43-lakh mark.
Maharashtra is followed by Andhra Pradesh with 5,17,094 cases. The state crossed Tamil Nadu to take up second place in the list due to a recent massive surge in the number of cases.
Tamil Nadu is third on the list with 4,74,940 cases.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
 "COVID-19 Vaccine News Update: Agreement with an Indian company")
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}